In this pandemic situation, where everyone tries to contribute his role to stop or control this dangerous virus from doctors to police and public organization NASA is also designed a high-pressure ventilator for COVID-19.
This high-pressure device is called VITAL which means Ventilator Intervention Technology Accessible Locally. It was developed by NASA’s Jet Propulsion Laboratory in Southern engineers. It helps to treat COVID-19 patients and help the nation to free up the shortage of traditional old ventilators. It can use to treat patients that have to sever COVID-19 symptoms.
JPL (Jet Propulsion Laboratory) Director Michael Watkins said:
“Our engineers are specialists in aircraft engineering not medical-device manufacture but from incredible engineering, meticulous testing, strong prototyping, and some of our specialists we designed it.”
VITAL can be design or builtin a short period and kept up more effectively than an old traditional ventilator and is made out of far fewer parts, a significant number of which are right now accessible to potential manufacturers through existing supply chains. Its adaptable structure implies it also can be adjusted for use in field emergency clinics being set up in assembly halls, restaurants, and other high-limit offices in the country US and around the world.
Before the FDA’s audit, the VITAL model breezed through a basic assessment on April 21 at the Icahn School of Medicine at Mount Sinai in New York. VITAL consists of a few advantages in the national reaction to COVID-19.
FDA Commissioner Stephen Hahn said:
“Battling with COVID-19 and treating patients during this remarkable worldwide pandemic requires creative methodologies and activity. It also takes an all active deck approach, as exhibited by the NASA engineers who utilized their mastery in the spacecraft to structure a ventilator custom-made for extremely sick coronavirus patients. This model shows what we can do when everybody cooperates to battle COVID-19. We accept the present activity will build accessibility of these life-sparing clinical ventilators.”
Like all ventilators, VITAL expects patients to be quieted and an oxygen tube embedded into their air route to breathe. The new ventilator wouldn’t supplant current emergency clinic ventilators, which can a year ago and are worked to address a more extensive scope of clinical issues. Rather, VITAL is proposed to last three to four months and is specifically for COVID-19 patients.
The Office of Technology Transfer and Corporate Partnerships at Caltech, which oversees JPL for NASA, is offering a free permit for VITAL and is connecting with the business clinical industry to discover makers for the high-pressure ventilator.